Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Larinject 50mg Injection

Prescription Icon
Prescription Required

Marketer

La Renon Healthcare Pvt Ltd

Salt Composition

Ferric Carboxymaltose (50mg)

Overview Larinject 50mg Injection

Ferinject 50mg is an iron supplement administered intravenously to address iron-deficiency anemia, a condition characterized by insufficient red blood cells due to inadequate iron. Red blood cell production, crucial for oxygen transport, requires iron. Administered via injection or intravenous infusion by a healthcare professional, Ferinject 50mg typically involves two doses a week apart, with frequency determined by your physician based on your response. Close monitoring for allergic reactions is standard. A balanced diet rich in iron (e.g., meat, eggs, legumes, dark leafy greens) complements treatment. Common, usually transient, side effects include nausea, headache, lightheadedness, elevated blood pressure, and injection site discomfort. Persistent or bothersome effects warrant medical attention. This medication is contraindicated if anemia isn't iron-deficient. Prior to use, disclose conditions such as rheumatoid arthritis, asthma, allergies, hypertension, or liver disease. Pregnancy or breastfeeding necessitates medical consultation. Regular blood tests monitor your iron levels, red blood cell count, treatment progress, and any adverse reactions. Limiting alcohol consumption during treatment is recommended.

Uses of Larinject 50mg Injection

Managing iron-deficiency anemia

Major Benefits of Larinject 50mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Larinject 50mg Injection:

  • Headache
  • Dizziness
  • High blood pressure
  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Nausea
  • Dark colored stool

How to use Larinject 50mg Injection:

The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Larinject 50mg Injection works:

Ferinject 50mg injection combats iron deficiency anemia by restoring depleted iron levels. This is crucial for red blood cell production and hemoglobin synthesis, enabling efficient oxygen transport throughout the body.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Larinject 50mg Injection may be unsafe; physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Larinject 50mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Larinject 50mg Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by a 50mg Larinject injection.

KidneyKidneySAFE IF PRESCRIBED

The use of Larinject 50mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.

LiverLiverCAUTION

For individuals with hepatic impairment, administration of Larinject 50mg Injection requires careful consideration. Dosage modification of Larinject 50mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Larinject 50mg Injection :

Omitting a scheduled dose of Larinject 50mg Injection necessitates contacting your physician.

Facts to Know About Larinject 50mg Injection

LabelValue
Chemical Type Carbohydrate-Iron Complex
Developing Habits No.
Treatment Category Obstetrics and Gynecology

FAQs on Larinject 50mg Injection

Trained personnel, equipped to manage anaphylaxis, should administer Larinject 50mg Injection. This injection may be given undiluted intravenously, via a dialysis line (if applicable), or as a sodium chloride infusion intravenously. Post-injection monitoring should last at least 30 minutes. Subcutaneous or intramuscular administration is contraindicated.
Store Larinject 50mg Injection vials at 20°C to 25°C (68°F to 77°F). Do not freeze. Maintain storage temperature within 15°C to 30°C (59°F to 86°F).
This medication is typically administered in two doses, one week apart. Hemoglobin levels are checked at least four weeks after the second dose to evaluate red blood cell production. Further treatment may be necessary if iron deficiency persists.
Larinject 50mg Injection can temporarily raise blood pressure, sometimes causing facial flushing, dizziness, and nausea. These side effects usually begin immediately after injection and subside within 30 minutes.
Larinject 50mg Injection leakage at the injection site may occur with improper administration. Stop administration immediately if leakage is observed, as this can cause skin irritation and persistent brown skin discoloration.
Pregnancy data on Larinject 50mg Injection is limited. Inform your doctor if you're pregnant, planning pregnancy, or become pregnant during treatment. Your doctor will determine if treatment should continue.
Larinject 50mg Injection
1,571
MRP 1,914
17% off